These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20381668)

  • 1. Determinants of adiponectin levels in patients with chronic systolic heart failure.
    Biolo A; Shibata R; Ouchi N; Kihara S; Sonoda M; Walsh K; Sam F
    Am J Cardiol; 2010 Apr; 105(8):1147-52. PubMed ID: 20381668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction.
    Tang WH; Shrestha K; Tong W; Wang Z; Troughton RW; Borowski AG; Klein AL; Hazen SL
    Transl Res; 2013 Jul; 162(1):26-33. PubMed ID: 23499315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ≥65 years of age (from the Cardiovascular Health study).
    Karas MG; Benkeser D; Arnold AM; Bartz TM; Djousse L; Mukamal KJ; Ix JH; Zieman SJ; Siscovick DS; Tracy RP; Mantzoros CS; Gottdiener JS; deFilippi CR; Kizer JR
    Am J Cardiol; 2014 Jan; 113(2):328-34. PubMed ID: 24169012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute systolic heart failure with normal admission BNP: clinical features and outcomes.
    Omar HR; Guglin M
    Int J Cardiol; 2017 Apr; 232():324-329. PubMed ID: 28094130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
    Graham S; Ye S; Qian M; Sanford AR; Di Tullio MR; Sacco RL; Mann DL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Labovitz AJ; Lip GY; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Thompson JL; Homma S;
    PLoS One; 2014; 9(11):e113447. PubMed ID: 25426862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    DeVore AD; McNulty S; Alenezi F; Ersboll M; Vader JM; Oh JK; Lin G; Redfield MM; Lewis G; Semigran MJ; Anstrom KJ; Hernandez AF; Velazquez EJ
    Eur J Heart Fail; 2017 Jul; 19(7):893-900. PubMed ID: 28194841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure.
    Melenovsky V; Kotrc M; Borlaug BA; Marek T; Kovar J; Malek I; Kautzner J
    J Am Coll Cardiol; 2013 Oct; 62(18):1660-1670. PubMed ID: 23916933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure.
    Baldasseroni S; Mannucci E; Orso F; Di Serio C; Pratesi A; Bartoli N; Marella GA; Colombi C; Foschini A; Valoti P; Mossello E; Fumagalli S; Marchionni N; Tarantini F
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):292-9. PubMed ID: 22032915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin correlates with body mass index and to a lesser extent with left ventricular mass in dialysis patients.
    Poniku A; Bajraktari G; Elezi S; Ibrahimi P; Henein MY
    Cardiol J; 2018; 25(4):501-511. PubMed ID: 28980284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study).
    Chrysohoou C; Pitsavos C; Barbetseas J; Kotroyiannis I; Brili S; Vasiliadou K; Papadimitriou L; Stefanadis C
    Heart Vessels; 2009 Jan; 24(1):22-6. PubMed ID: 19165564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.
    Lupón J; Gaggin HK; de Antonio M; Domingo M; Galán A; Zamora E; Vila J; Peñafiel J; Urrutia A; Ferrer E; Vallejo N; Januzzi JL; Bayes-Genis A
    Int J Cardiol; 2015 Apr; 184():337-343. PubMed ID: 25734941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.
    Fujimura M; Akaike M; Iwase T; Yoshida S; Sumitomo Y; Yagi S; Ikeda Y; Hashizume S; Aihara K; Nishiuchi T; Yasumura Y; Matsumoto T
    Acta Cardiol; 2009 Oct; 64(5):589-95. PubMed ID: 20058503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography.
    Cavusoglu E; Chopra V; Battala V; Ruwende C; Yanamadala S; Eng C; Pinsky DJ; Marmur JD
    Am J Cardiol; 2008 Apr; 101(8):1073-8. PubMed ID: 18394435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
    Feola M; Aspromonte N; Canali C; Ceci V; Giovinazzo P; Milani L; Quarta G; Ricci R; Scardovi AB; Uslenghi E; Valle R
    Am J Cardiol; 2005 Sep; 96(5):705-9. PubMed ID: 16125500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure.
    Bosselmann H; Tonder N; Sölétormos G; Gaborit F; Rossing K; Iversen K; Goetze JP; Gustafsson F; Schou M
    ESC Heart Fail; 2017 Nov; 4(4):554-562. PubMed ID: 29154425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Baseline versus Posttreatment Left Ventricular Ejection Fraction in Patients with Acute Decompensated Heart Failure for Predicting Cardiovascular Outcome: Implications from Single-Center Systolic Heart Failure Cohort.
    Yeh JK; Hsiao YC; Jian CR; Wang CH; Wen MS; Kuo CT; Tsai FC; Wu VC; Chen TH
    PLoS One; 2016; 11(1):e0145514. PubMed ID: 26752417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular diseases and systolic function of left ventricle in clean up workers of Chernobyl accident (based on 30 years follow up).
    Bazyka OD; Belyi DO
    Probl Radiac Med Radiobiol; 2017 Dec; 22():292-305. PubMed ID: 29286514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.
    Yamaji M; Tsutamoto T; Tanaka T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ J; 2009 Jun; 73(6):1067-73. PubMed ID: 19367012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.